2021
DOI: 10.1093/jn/nxab038
|View full text |Cite
|
Sign up to set email alerts
|

Letrozole-Induced Polycystic Ovary Syndrome Attenuates Cystathionine-β Synthase mRNA and Protein Abundance in the Ovaries of Female Sprague Dawley Rats

Abstract: Background Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects 10% of reproductive-aged women and leads to hyperandrogenism, anovulation, and infertility. PCOS has been associated with elevated serum homocysteine as well as altered methylation status; however, characterization of one-carbon metabolism (OCM) in PCOS remains incomplete. Objectives The aim of our research was to assess OCM in a letrozole-induc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
1
1
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…Our previous study indicated that rats with administration of LET subcutaneously for 12 weeks showed both the reproductive and metabolic alterations as PCOS patients have [18]. Although many studies have used LET-induced animal models to study the pathogenesis and pharmacological treatment related to PCOS, most of them focus on the characteristics related to the end induction of the model [19][20][21][22][23][24], and only a few experiments have been conducted to investigate the pathological mechanisms of LET-induced PCOS model animals at different time points [25,26]. Further, few studies work on investigating the regulation of inflammatory response during the pathogenesis of PCOS.…”
Section: Introductionmentioning
confidence: 99%
“…Our previous study indicated that rats with administration of LET subcutaneously for 12 weeks showed both the reproductive and metabolic alterations as PCOS patients have [18]. Although many studies have used LET-induced animal models to study the pathogenesis and pharmacological treatment related to PCOS, most of them focus on the characteristics related to the end induction of the model [19][20][21][22][23][24], and only a few experiments have been conducted to investigate the pathological mechanisms of LET-induced PCOS model animals at different time points [25,26]. Further, few studies work on investigating the regulation of inflammatory response during the pathogenesis of PCOS.…”
Section: Introductionmentioning
confidence: 99%